Literature DB >> 12540742

Nitric oxide-releasing drugs.

Claudio Napoli1, Louis J Ignarro.   

Abstract

Pharmacological compounds that release nitric oxide (NO) have been useful tools for evaluating the broad role of NO in physiology and therapeutics. NO deficiency has been implicated in the genesis and evolution of several disease states. Both medical needs and commercial opportunities have fostered attempts to modulate NO in the human body for therapeutic gain. Strategies for NO modulation encompass antiinflammatory, sexual dysfunction, and cardiovascular indications. Apart from newly developed drugs, several commonly used cardiovascular drugs exert their beneficial action, at least in part, by modulating the NO pathway. This review discusses the fundamental pharmacological properties and mechanisms of action of NO-releasing drugs. Some of these compounds may enter in the clinical arena providing important therapeutic benefits in human diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12540742     DOI: 10.1146/annurev.pharmtox.43.100901.140226

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  42 in total

Review 1.  Nitrates and nitrites in the treatment of ischemic cardiac disease.

Authors:  Vaughn E Nossaman; Bobby D Nossaman; Philip J Kadowitz
Journal:  Cardiol Rev       Date:  2010 Jul-Aug       Impact factor: 2.644

2.  Photoactive Ruthenium Nitrosyls: Effects of Light and Potential Application as NO Donors.

Authors:  Michael J Rose; Pradip K Mascharak
Journal:  Coord Chem Rev       Date:  2008-10-01       Impact factor: 22.315

3.  S-nitrosothiol tethered polymer hexagons: synthesis, characterisation and antibacterial effect.

Authors:  S Priya; R Nithya; Sheela Berchmans
Journal:  J Mater Sci Mater Med       Date:  2013-08-31       Impact factor: 3.896

Review 4.  Glutathione S-transferases as regulators of kinase pathways and anticancer drug targets.

Authors:  Danyelle M Townsend; Victoria L Findlay; Kenneth D Tew
Journal:  Methods Enzymol       Date:  2005       Impact factor: 1.600

Review 5.  Recent developments in nitric oxide donor drugs.

Authors:  M R Miller; I L Megson
Journal:  Br J Pharmacol       Date:  2007-04-02       Impact factor: 8.739

Review 6.  Application of metal coordination chemistry to explore and manipulate cell biology.

Authors:  Kathryn L Haas; Katherine J Franz
Journal:  Chem Rev       Date:  2009-10       Impact factor: 60.622

7.  Physical training and metabolic supplementation reduce spontaneous atherosclerotic plaque rupture and prolong survival in hypercholesterolemic mice.

Authors:  Claudio Napoli; Sharon Williams-Ignarro; Filomena de Nigris; Lilach O Lerman; Francesco P D'Armiento; Ettore Crimi; Russell E Byrns; Amelia Casamassimi; Alessandro Lanza; Fernando Gombos; Vincenzo Sica; Louis J Ignarro
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-26       Impact factor: 11.205

Review 8.  Inorganic nitrite therapy: historical perspective and future directions.

Authors:  Christopher G Kevil; Gopi K Kolluru; Christopher B Pattillo; Tony Giordano
Journal:  Free Radic Biol Med       Date:  2011-05-04       Impact factor: 7.376

Review 9.  Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis.

Authors:  Louis J Ignarro; Claudio Napoli
Journal:  Curr Atheroscler Rep       Date:  2004-07       Impact factor: 5.113

10.  Biological targets for isatin and its analogues: Implications for therapy.

Authors:  Alexei Medvedev; Olga Buneeva; Vivette Glover
Journal:  Biologics       Date:  2007-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.